ADMA Biologics (ADMA)
US Market

ADMA Biologics Financial Statements


ADMA Biologics Financial Overview

ADMA Biologics's market cap is currently ―. The company's EPS TTM is $-0.422; its P/E ratio is -5.75; ADMA Biologics is scheduled to report earnings on November 10, 2022, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 33.91M$ 29.10M$ 26.38M$ 20.68M$ 17.83M
Gross Profit$ 7.77M$ 3.66M$ 3.51M$ 385.34K$ -1.00M
EBIT$ -9.19M$ -21.62M$ -13.33M$ -14.41M$ -15.66M
EBITDA$ -7.47M$ -20.03M$ -11.82M$ -12.99M$ -14.33M
Net Income Common Stockholders$ -13.76M$ -25.01M$ -16.65M$ -17.71M$ -18.91M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 34.41M$ 42.41M$ 51.09M$ 52.42M$ 55.92M
Total Assets$ 296.93M$ 308.03M$ 276.25M$ 238.64M$ 232.81M
Total Debt$ 97.58M$ 100.15M$ 100.27M$ 101.34M$ 101.78M
Net Debt$ 63.17M$ 57.74M$ 49.18M$ 48.92M$ 45.86M
Total Liabilities$ 182.53M$ 181.10M$ 135.08M$ 135.86M$ 121.22M
Stockholders Equity$ 71.38M$ 88.25M$ 102.78M$ 111.59M$ 112.50M
Cash Flow
Free Cash Flow$ -16.77M$ -28.86M$ -37.14M$ -16.20M$ -36.74M
Operating Cash Flow$ -12.83M$ -26.01M$ -33.47M$ -13.41M$ -32.26M
Investing Cash Flow$ -3.94M$ -2.84M$ -3.68M$ -2.79M$ -4.48M
Financing Cash Flow$ -319.04K$ 47.27M$ 53.82M$ 8.20M$ 17.18M
Currency in USD

ADMA Biologics Earnings and Revenue History

ADMA Biologics Debt to Assets

ADMA Biologics Cash Flow

ADMA Biologics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis